Fluzoparib With or Without Bevacizumab for Neoadjuvant Therapy in Advanced Ovarian Cancer
Clinical trial NCT06735326 · RECRUITING
Trial details
- NCT number
- NCT06735326
- Sponsor
- Qilu Hospital of Shandong University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-27
- Primary completion
- 2026-08-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.